FDA Approves Amondys 45 (casimersen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in Patients Amenable to Skipping Exon 45

FDA Approves Amondys 45 (casimersen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in Patients Amenable to Skipping Exon 45 CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) —  Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved Amondys… Read More »

KHN’s ‘What the Health?’: Staffing Up at HHS

Can’t see the audio player? Click here to listen on SoundCloud. More than a month into President Joe Biden’s term, nominees to fill some of the top posts at the Department of Health and Human Services are finally getting confirmation hearings in the Senate, starting with the nominee for secretary, California Attorney General Xavier Becerra. Barring… Read More »

Friday Faves

Hi friends! Happy Friday. I hope you had a wonderful week. It’s the kids’ Rodeo Break (it’s a Tucson thing!) so it’s been so nice having a break from virtual school and dance classes for the crew. It reminds me of the slower days of summer and I’m LOVING it: sleeping in, taking lots of… Read More »